These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The effect of 5-fluorouracil on Dupuytren fibroblast proliferation and differentiation. Jemec B, Linge C, Grobbelaar AO, Smith PJ, Sanders R, McGrouther DA. Chir Main; 2000 Feb; 19(1):15-22. PubMed ID: 10777424 [Abstract] [Full Text] [Related]
10. The role of an MMP inhibitor in the regulation of mechanical tension by Dupuytren's disease fibroblasts. Townley WA, Cambrey AD, Khaw PT, Grobbelaar AO. J Hand Surg Eur Vol; 2009 Dec; 34(6):783-7. PubMed ID: 19786408 [Abstract] [Full Text] [Related]
12. Dupuytren's disease: comparative growth dynamics and morphology between cultured myofibroblasts (nodule) and fibroblasts (cord). Vande Berg JS, Gelberman RH, Rudolph R, Johnson D, Sicurello P. J Orthop Res; 1984 Dec; 2(3):247-56. PubMed ID: 6491814 [Abstract] [Full Text] [Related]
13. A study of Dupuytren's tissue with the scanning electron microscope. Legge JW, Finlay JB, McFarlane RM. J Hand Surg Am; 1981 Sep; 6(5):482-92. PubMed ID: 7276480 [Abstract] [Full Text] [Related]
16. Increased metabolic activity of fibroblasts derived from cords compared with nodule fibroblasts sampling from patients with Dupuytren's contracture. Seyhan H, Kopp J, Schultze-Mosgau S, Horch RE. Plast Reconstr Surg; 2006 Apr; 117(4):1248-52. PubMed ID: 16582795 [Abstract] [Full Text] [Related]
17. Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells. Vi L, Feng L, Zhu RD, Wu Y, Satish L, Gan BS, O'Gorman DB. Exp Cell Res; 2009 Dec 10; 315(20):3574-86. PubMed ID: 19619531 [Abstract] [Full Text] [Related]
18. The potential roles of cell migration and extra-cellular matrix interactions in Dupuytren's disease progression and recurrence. Vi L, Gan BS, O'Gorman DB. Med Hypotheses; 2010 Mar 10; 74(3):510-2. PubMed ID: 19896280 [Abstract] [Full Text] [Related]
19. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease. Ulrich D, Ulrich F, Piatkowski A, Pallua N. Arch Orthop Trauma Surg; 2009 Nov 10; 129(11):1453-9. PubMed ID: 18758795 [Abstract] [Full Text] [Related]
20. Pharmacologic regulation of Dupuytren's fibroblast contraction in vitro. Rayan GM, Parizi M, Tomasek JJ. J Hand Surg Am; 1996 Nov 10; 21(6):1065-70. PubMed ID: 8969433 [Abstract] [Full Text] [Related] Page: [Next] [New Search]